| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |